Cervical Cancer Survival Rate:
The following table shows the overall survival rates for cervical cancer according to age group.
Age Group Overall Survival Rate (95% Confidence Interval) 15–24 Years 50% 25–34 Years 35% 35–44 Years 30% 45–54 Years 20% 55+ Years 10%
Survival Rates For Women Under Age 18:
The following table shows the overall survival rates for women under age 18.
Age Group Overall Survival Rate (95% Confidence Interval) 0 – 4 years 65.0 5 – 9 years 85.6 10 – 14 years 92.2 15 – 19 years 97.5
Prognosis For Cervical Cancer:
The table below summarizes various prognostic factors that are known to be associated with survival in patients with Cervical Cancer.
Prognostic Factor Median Overall Survival (95% Confidence Interval) Age (years) 30 (26 – 35) 0.9 (.8 – 1.4) Stage* I 46 II 35 IIIB 21 IVA 7 IVB 5 Recurrence 23 0.9 (.7 – 1.2) Histology Grade I 51 Grade II 35 Grade III 23 pN0 26 0.8 (.5 – 1.1) pNX 41 0.7 (.5 – 1.0)
Treatment For Cervical Carcinoma In Situ:
The following treatment options are used for patients with cervical cancer in situ.
Surgery is the treatment of choice for patients with early stage of cervical cancer. The most common surgical procedure for this condition is the surgery, which provides the best chance for cure.
The following therapies can be used as adjuvant therapy for patients with cervical cancer in situ who have undergone surgery.
Chemotherapy is the treatment of choice for patients with extensive stage of the cancer, or if the disease has spread to other parts of the body. The most common types of chemotherapy used for this condition include Cisplatin and Cyclophosphamide.
Hormonal therapy can be used to treat patients with advanced or recurrent disease.
Targeted therapy is used in patients who are found to have specific alterations.
Re-irradiation is used to treat patients with persistent or recurrent disease.
Immunotherapy is used to treat patients who have not responded to other types of treatment.
The prognosis of this condition depends on the stage and type of cancer, the overall health of the patient, and the treatment that is used.
General information about Cervical Carcinoma In Situ:
Cervical cancer (also called uterine cancer) starts in the lining of the womb (uterus). It is more common in women over the age of 30 and less common in women under the age of 20. The cancer begins when cells in the lining begin to multiply more quickly than normal and form a mass. This mass is called a tumor.
Over time, the tumor can grow and invade nearby organs. If it invades nearby blood vessels, then it can spread to other parts of the body. This is called metastasis.
The most common symptom is abnormal bleeding from the womb, such as after menopause. These symptoms are not specific to cervical cancer and can also be caused by uterine fibroids, endometriosis or an STD. These need to be ruled out before a diagnosis of cancer is considered.
If cervical cancer is diagnosed, early stages can be cured by surgery. Later stages are treated with a combination of surgery, chemotherapy and radiation.
Bibliography:
Cancer Research UK: Cervical cancer
Mayo Clinic: Cervical cancer
NHS: Cervical cancer
Wikipedia: Cervical cancer
Mayo Clinic: Uterine cancer
Medscape: Cervical cancer
Google Images: Cervical cancer
CDC: Cancer Facts and Figures 2013
Clinical Key: Cervical cancer
Wikipedia: Human papillomavirus
Like this: Like Loading…
Sources & references used in this article:
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study by N Ylitalo, P Sørensen, AM Josefsson, PKE Magnusson… – The Lancet, 2000 – Elsevier
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer by H Arias-Pulido, CL Peyton, NE Joste… – Journal of clinical …, 2006 – Am Soc Microbiol
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study by AM Josefsson, PKE Magnusson, N Ylitalo, P Sørensen… – The Lancet, 2000 – Elsevier
Type‐specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ by M Moberg, I Gustavsson… – International journal of …, 2004 – Wiley Online Library
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ by N Ylitalo, A Josefsson, M Melbye, P Sörensen, M Frisch… – Cancer research, 2000 – AACR
The significance of cervical carcinoma in situ by GH Green – American Journal of Obstetrics & Gynecology, 1966 – ajog.org
Smoking and oral contraceptives as risk factors for cervical carcinoma In situ by N Ylitalo, P Sørensen, A Josefsson… – … Journal of Cancer, 1999 – Wiley Online Library
… hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced‐stage cervical carcinoma by M Kirchhoff, H Rose, BL Petersen… – Genes …, 1999 – Wiley Online Library
